Yuchun F. Gu

Yiheyuan Road
Beijing, 100871, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Bone matrix-mimetic DLP-printable gelatin and hyaluronic acid nanocomposite hydrogels for cranial defect repair.

Bone matrix-mimetic DLP-printable gelatin and hyaluronic acid nanocomposite hydrogels for cranial defect repair.

Journal: International journal of biological macromolecules

Published: April 10, 2026

Retraction Note: Circular RNA circDCUN1D4 suppresses hepatocellular carcinoma development via targeting the miR-590-5p/ TIMP3 axis.

Retraction Note: Circular RNA circDCUN1D4 suppresses hepatocellular carcinoma development via targeting the miR-590-5p/ TIMP3 axis.

Journal: Molecular cancer

Published: January 06, 2026

Mesenchymal stem cells therapy for immune thrombocytopenia in pregnancy: a case report.

Mesenchymal stem cells therapy for immune thrombocytopenia in pregnancy: a case report.

Journal: BMC pregnancy and childbirth

Published: May 25, 2025

A scalable platform for EPSC-Induced MSC extracellular vesicles with therapeutic potential.

A scalable platform for EPSC-Induced MSC extracellular vesicles with therapeutic potential.

Journal: Stem cell research & therapy

Published: March 28, 2025

FAK signaling suppression by OCT4-ITGA6 mediates the effectively removal of residual pluripotent stem cells and enhances application safety.

FAK signaling suppression by OCT4-ITGA6 mediates the effectively removal of residual pluripotent stem cells and enhances application safety.

Journal: Theranostics

Published: January 27, 2025

Circular RNA circDCUN1D4 suppresses hepatocellular carcinoma development via targeting the miR-590-5p/ TIMP3 axis.

Circular RNA circDCUN1D4 suppresses hepatocellular carcinoma development via targeting the miR-590-5p/ TIMP3 axis.

Journal: Molecular cancer

Published: October 22, 2024

CircITGA7 overexpression suppresses HCC progression via miR-330/BCL11B axis regulation.

CircITGA7 overexpression suppresses HCC progression via miR-330/BCL11B axis regulation.

Journal: Cancer cell international

Published: June 05, 2024

The isoflavone puerarin promotes generation of human iPSC-derived pre-oligodendrocytes and enhances endogenous remyelination in rodent models.

The isoflavone puerarin promotes generation of human iPSC-derived pre-oligodendrocytes and enhances endogenous remyelination in rodent models.

Journal: Journal of neurochemistry

Published: March 21, 2024

Human iPSC-derived endothelial cells promote CNS remyelination via BDNF and mTORC1 pathway.

Human iPSC-derived endothelial cells promote CNS remyelination via BDNF and mTORC1 pathway.

Journal: Glia

Published: September 01, 2022

Universal Markers for hiPSCs Residue Detection.

Universal Markers for hiPSCs Residue Detection.

Journal: Frontiers in bioscience (Landmark edition)

Published: May 27, 2022

Combined treatment with anti-PSMA CAR NK-92 cell and anti-PD-L1 monoclonal antibody enhances the antitumour efficacy against castration-resistant prostate cancer.

Combined treatment with anti-PSMA CAR NK-92 cell and anti-PD-L1 monoclonal antibody enhances the antitumour efficacy against castration-resistant prostate cancer.

Journal: Clinical and translational medicine

Published: January 25, 2022

The establishment of polypeptide PSMA-targeted chimeric antigen receptor-engineered natural killer cells for castration-resistant prostate cancer and the induction of ferroptosis-related cell death.

The establishment of polypeptide PSMA-targeted chimeric antigen receptor-engineered natural killer cells for castration-resistant prostate cancer and the induction of ferroptosis-related cell death.

Journal: Cancer communications (London, England)

Published: December 01, 2021

Showing 1-12 of 49

Last Updated: 09/26/2026